Carcinoma of Unknown Primary — Trials

Carcinoma of Unknown Primary — Trials · CancerIndex

Clinical trials

Registered studies

14,235 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4,156
Recruiting: 2,259
Ph III recruiting: 267
Growth YoY: +12.6%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,895)

clinicaltrialsPublishedShowing 751–800 of 5,039 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02133196	T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer	recruiting	Phase 2	85	National Cancer Institute (NCI)NIH	1	Aug 31, 2026	clinicaltrials
NCT02305654	International Penile Advanced Cancer Trial (International Rare Cancers Initiative Study)(InPACT)	active not recruiting	Phase 3	200	Institute of Cancer Research, United KingdomOTHER	2	Aug 31, 2026